Speaker illustration

Professor Basil S Lewis

Technion - Israel Institute of Technology, Haifa (Israel)

Member of:

European Society of Cardiology
Heart Failure Association

Professor Basil Lewis is Co-Chairperson of the Pharmacology and Pharmacotherapy Committee of the HFA. He is a Past President of the Israel Heart Society and was the founding Chair of the Israel Working Group on Heart Failure. Professor Lewis obtained his medical degrees from the University of the Witwatersrand, Johannesburg, South Africa (MBBCh; MD) and undertook post-graduate training at the Cedars-Sinai Medical Center in Los Angeles CA, USA. His current scientific interest focuses on the conduct, practice, and teaching of clinical trials, especially in the fields of heart failure, acute coronary syndromes, antithrombotic drugs, and cardiometabolic diseases. Professor Lewis is based in Haifa, Israel at the Ruth and Bruce Rappaport School of Medicine of the Technion-Israel Institute of Technology.

Epigenetic targets of cardiovascular disease-from mechanism to therapy

Event: HFA Winter Research Meeting on Translational Heart Failure 2023

Topic: Genetics, Epigenetics, ncRNA

Session type: Symposium

Thumbnail

Regulatory Aspects

Event: All About Clinical Trials (AACT)

Topic: Research Methodology

Session type: Teaching Course

Thumbnail

Meet the Experts: medical treatment for chronic coronary syndromes

Event: ESC Congress 2022

Topic: Treatment

Session type: Meet the Experts

Thumbnail

Congress committee e-posters choice in pharmacology and pharmacotherapy

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacology and Pharmacotherapy

Session type: Congress Committee e-posters Choice

Thumbnail

Controversies in antithrombotic treatment for primary and secondary prevention

Event: ESC Congress 2019

Topic: Cardiovascular Pharmacotherapy

Session type: Debate Session

Thumbnail

PCSK9 inhibitors: from cells to patients

Event: ESC Congress 2019

Topic: PCSK9-Antagonists

Session type: Advances in Science

Thumbnail

Late Breaking Science in Cardiovascular Pharmacology

Event: ESC Congress 2019

Topic: Pharmacology and Pharmacotherapy

Session type: Late-Breaking Science

Thumbnail

Crunching the numbers: how to critically analyse a clinical trial

Event: ESC Congress 2017

Topic: Miscellaneous

Session type: Special Session

Thumbnail

Pharmacotherapy of heart failure

Event: ESC Congress 2016

Topic: Drug therapy

Session type: Symposium

Thumbnail

Still learning of DAPT: Clopidogrel out of the game?

Event: ESC Congress 2016

Topic: Drug therapy

Session type: Advances in Science

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb